临床研究组织ICON plc近日披露，经审计发现公司历年营收确认存在轻微高报情况，但各年度偏差幅度均控制在2%的阈值之内。值得注意的是，2025财年受此影响的财务数据波动较此前年份呈现收窄趋势。
根据内部核查结果，收入确认差异主要源于部分长期合同的服务进度计量方式调整。公司强调该偏差属于非实质性会计处理差异，且已通过后续会计期间进行自然抵销，不会对整体财务报表的公允性产生重大影响。
财务总监在电话会议中透露，2025年度的营收修正幅度预计将低于2020-2024年期间的平均水平，这反映出公司财务内控体系持续优化的积极成效。目前审计委员会已完善相关合同收入确认的复核机制，确保未来财务数据能更精准反映业务实质。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.